Professional Documents
Culture Documents
Hemostasis
BV Injury
Tissue Factor
Lab Tests
CBC-Plt BT,(CT) PT PTT
Neural
Coagulation Cascade
Fibrin formation
Plt Study
Stable Hemostatic Plug
Platelet
Coagulation
Petechiae, Purpura
Senile Purpura
Bleeding time = time to complete cessation of free blood flow from incision
Thrombocytopenia Causes
Marrow injury/failure - aplastic or myelophthesic anemia - drugs, infections - megaloblastic anemia, PNH Decreased survival - immune (ITP, drugs, infections) - nonimmune (DIC, TTP)
Acute - children (post infection) Chronic - adults ( females, 20-40 yrs) - autoimmune disorder - antiplatelet antibodies (IgG against platelet glycoproteins) - IgG coated platelets removed by spleen ( platelet survival)
Platelet dysfunction:
Inherited - autosomal recessive Bernard-Soulier disease - large platelets - lack of glycoproteins (1b-IX complex) - failure of platelet adhesion Glanzmanns thrombasthenia - normal platelet morphology - lack of glycoproteins (IIb-IIIa complex)
Secondary Hemostasis
Consolidates initial platelet plug into stable clot Disorders - deficiencies of plasma clotting factors Clinical - bleeding from large vessels into joints (hemarthroses), muscles, deep soft tissues (hematomas, large ecchymoses)
Laboratory findings: Normal bleeding time, platelet count Prolonged prothrombin time (PT) deficiencies of II, V, VII, X Prolonged activated partial thromboplastin time (aPTT) all factors except VII, XIII Mixing studies - normal plasma
A) X-linked disorder (affects 1 males) Most common hereditary disease with severe bleeding 30% new mutations (not hereditary)
Factor IX Deficiency
Christmas disease (hemophilia B) X-linked recessive disorder Indistinguishable from classic hemophilia Requires evaluation of factor VIII and IX activity levels to diagnose Treatment - factor IX concentrate
von Willebrands Disease Autosomal dominant (or recessive) Primary defect - platelet adhesion (prolonged bleeding time) Secondary defect - deficiency of factor VIII; normally stabilizes factor VIII in
Clinical - often mild - excessive bleeding from wounds - spontaneous bleeding from mucous membranes Different types - quantity or loss of selective multimers Diagnosis - ristocetin induced plt aggregation or multimer
Disseminated Intravascular Coagulation Primary - platelet consumption ( bleeding time, platelets) Secondary - factor consumption ( PT, aPTT) Major pathologic processes obstetric complications, neoplasms, infection (sepsis),
Microvascular thrombosis
Clotting factor Tissue injury, consumption Fibrinolysis Hemolytic anemia Fibrin split products Bleeding plasmin
Acute DIC - bleeding - i.e. major trauma - give fresh frozen plasma Chronic DIC - thrombosis - i.e. cancer - give heparin or anticoagulant
Severe Liver Disease Primary - dysfunctional platelets and/or thrombocytopenia ( BT) Secondary - decrease in all coagulation factors except vWF ( PT, aPTT) Vitamin K will promote synthesis of factors II, VII, IX, X
PTT
1o hemostasis 2o Factor VIII/IX deficiency 2o Vitamin K deficiency - - -
Approach to bleeding disorders Personal history of bleeding With surgery Tonsillectomy, circumcision Epistaxis a Immediate bleeding after trauma or surgery suggest platelet or severe protein deficiency. Bleeding 2-5 days post trauma or surgery suggest plasma protein deficiency .
Family history X linked Autosomal al * Drug history Oral anticoagulant, Heparin, Aspirin * Physical examination
Initial lab works CBC : Platelet count PT (INR) APTT Bleeding time
Petechiae
Hematom a
Hemarthrosis
Hematom a
Ecchymosis
Management : Always be on the safe side Dont do invasive procedures if you are in doubt. Always check with haematology/ internal medicine. Check the above tests if normal you can proceed Remember some cases of bleeding tendency might go first to you, like AML with gingival hyper trophy. Always check Drugs
HEPARIN THERAPY
Enhances activity of AT III Parenteral administration required Onset of action immediate Monitor aPTT Lower dose may work in patients without active thrombosis
HEPARIN THERAPY
Low Molecular Weight HeparinAdvantages
Less heterogeneous than heparin Less inhibition of platelet function Longer half life - Can give 1-2x/day Much less thrombocytopenia ? safer, equally effective
HEPARIN
Low Molecular Weight HeparinDisadvantages
Bleeding-? Less than with heparin (probably not) Most cross react with heparin RE: thrombocytopenia Each preparation is different Less overall experience with the drug
COUMADIN (warfarin)
Mechanism of Action
Inhibits Vitamin K dependent carboxylase activity Prevents reduction of Vitamin K Humans secrete des--carboxyglutamic acid, an inactive protein DOES NOT AFFECT PROTEINS ALREADY SYNTHESIZED Monitor using prothrombin time Multiple interactions with other drugs Antidote-Vitamin K
What do if no help if INR< 1.5 safe to do procedures, so if patient on Warfarin , stop Warfarin 2 days before surgery. Heparin stop if unfractionated 2 hours before SX. If low MW Heparin 4-6 hours stop surgery
Platelet defect: Count : Thrombocytopenia = low platelet count Thrombocytosis = High platelet count Safe procedure if platelet count above 50,000. Thrombosthenia : The count is normal but the function is abnormal.
Systemic illnesses can predispose to bleeding like liver diseases, Chronic renal failure.
Depending on the underlying cause abnormalities of the platelet should be corrected before any procedure . How to correct depends on the underlying cause either with platelets transfusion or other modalities to increase the count ,like steroids , IVIg in ITP.
If on Aspirin please stop Aspirin at least one week before SX. If urgent please check bleeding time if prolonged please give platelets. Which should be 1-2 hour before SX.
leukaemias
Can predispose to bleeding due to 1- low platelets count 2- DIC 3-Hyerviscosity syndrome. Oral manifestations of acute leukaemia Includes : gingival hypertrophy, bleeding , and ulcers.